Trial intelligence / Profile preview

Responsiveness to botulinum toxin type A in CRPS-related fixed dystonia

2010-019997-33Phase 4Active

Sponsor
Leiden University Medical Center
Start
Apr 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of botulinum toxin type A in complex regional pain syndrome (CRPS) and dystonia (3 arms), sponsored by Leiden University Medical Center. Started Apr 2010; status: active.

02

Drugs

botulinum toxin type A
03

Conditions

complex regional pain syndrome (CRPS)dystonia

Beyond the preview

Go deeper on 2010-019997-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019997-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call